NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-290-2006-2-ES-30 MIR-29a for diagnosing poor survival prognosis colon adenocarcinoma. ES EP 11196262.7 Abandoned
NCI E-021-2001-0-JP-14 Chromosome 3p21.3 Genes Are Tumor Suppressors JP DIV 2011-168826 Expired
NICHD E-001-2011-0-PCT-02 Serpinin And Variants Thereof For Increasing Heart Contractility And Treating Cardiovascular Diseases PCT PCT PCT/US2011/067375 Abandoned
NHLBI E-017-2012-0-US-01 Methods of Treating Or Preventing Viral Diseases By Blocking Interleukin-213 US 61/579,801 Abandoned
NIA E-205-2006-2-US-15 Preparation Of (R,R)-Fenoterol And R,R-OR (R,S)-Fenoterol Analogues And Their Use In Treating Congestive Heart Failure US CON 13/333,866 8703826 Issued PDF
NIA E-088-2007-1-US-07 METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION US DIV 13/332,800 8617813 Issued PDF
NHLBI E-207-2011-0-US-01 Multilayer-Coated Micro Grating Array For X-Ray Phase Sensitive And Scattering Sensitive Imaging US 61/578,719 Abandoned
NCI E-183-2009-0-US-03 SCHWEINFURTHINS AND USES THEREOF US National Stage 13/266,841 8686016 Issued PDF
NIEHS E-130-2004-0-AU-08 Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions AU DIV 2011265315 Issued
NIBIB E-243-2010-0-PCT-02 Tetrahertz Spatial Light Modulator System for Adaptive Near Field Imaging PCT PCT PCT/US11/065734 Abandoned
NCI E-088-2005-0-EP-10 System for Treating and Preventing Breast Cancer EP DIV 11009923.1 Abandoned
NCATS E-276-2011-0-US-01 Compounds And Methods For The Prevention And Treatment of Tumor Metastasis And Tumorigenesis US 61/576,780 Abandoned
NIAID E-279-2011-0-US-01 Methods of Producing T Cell Populations Enriched for Stable Regulatory T Cells US 61/576,837 Abandoned
CC E-015-2012-0-US-03 Tumor Abalation Training System US National Stage 13/378,412 11562665 Issued PDF
NIA E-146-1993-0-US-56 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 13/327,548 Abandoned
NICHD E-302-2011-0-US-01 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C US 61/576,062 Abandoned
NIAID E-043-2011-0-ZA-11 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines ZA National Stage 2013/04260 Abandoned
NIAID E-043-2011-0-BR-04 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines BR National Stage BR112013014712-1 Abandoned
NIAID E-043-2011-0-IN-07 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines IN National Stage 5348/CHENP/2013 Abandoned
NIAID E-043-2011-0-CA-05 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines CA National Stage 2821289 Issued
NIAID E-043-2011-0-KR-09 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines KR National Stage 10-2013-7016833 Abandoned
NIAID E-043-2011-0-ES-21 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines ES EP 11849865.8 Issued
NIAID E-043-2011-0-SE-28 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines SE EP 11849865.8 Abandoned
NIAID E-043-2011-0-PL-27 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines PL EP 11849865.8 Abandoned
NIAID E-043-2011-0-IT-25 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines IT EP 11849865.8 Issued
NIAID E-043-2011-0-IE-24 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines IE EP 11849865.8 Abandoned
NIAID E-043-2011-0-GB-23 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines GB EP 11849865.8 Issued
NIAID E-043-2011-0-CH-18 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines CH EP 11849865.8 Abandoned
NIAID E-043-2011-0-BE-17 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines BE EP 11849865.8 Abandoned
NIAID E-043-2011-0-EP-14 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines EP National Stage 11849865.8 Issued
NIAID E-043-2011-0-FR-22 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines FR EP 11849865.8 Issued
NIAID E-043-2011-0-DE-19 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines DE EP 11849865.8 Issued
NIAID E-043-2011-0-DK-20 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines DK EP 11849865.8 Abandoned
NIAID E-043-2011-0-NL-26 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines NL EP 11849865.8 Abandoned
NIAID E-043-2011-0-EA-13 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines EA National Stage 201390866 Abandoned
NIAID E-043-2011-0-AP-12 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines AP National Stage AP/P/2013/006972 Abandoned
NIAID E-043-2011-0-JP-08 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines JP National Stage 2013-544747 Issued
NIAID E-043-2011-0-AU-03 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines AU National Stage 2011343798 Abandoned
NIAID E-043-2011-0-CN-06 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines CN National Stage 201180067429.7 Issued
NCI E-021-2011-0-PCT-02 Synthetic Peptide Inhibitors Of WNT Pathway PCT PCT PCT/US2011/064902 Expired
NCI E-021-2011-0-EP-04 Synthetic Peptide Inhibitors Of WNT Pathway EP National Stage 11806070.6 Abandoned
NIAID E-043-2011-0-PCT-02 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines PCT PCT PCT/US2011/064944 Expired
NIAID E-240-2012-0-US-01 CD-4 Mimetic Inhibitors Of HIV Entry And Methods Of Use Thereof US 61/570,536 Abandoned
NIEHS E-130-2004-0-US-07 METHODS RELATED TO THE TREATMENT OF NEURODEGENERATIVE AND INFLAMMATORY CONDITIONS US CON 13/324,876 8796302 Issued PDF
NCI E-018-2011-0-PCT-02 Methods For Decreasing Body Weight And Treating Diabetes PCT PCT PCT/US2011/064690 Expired
NCI E-063-2003-0-US-06 Rapamycin-Resistant T Cells and Therapeutic Uses Thereof US CON 13/323,323 Abandoned
NIDDK E-234-2011-1-US-01 Conjugating Amines US 61/569,632 Abandoned
NIAID E-043-2011-0-AO-15 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines AO National Stage 2491-11-09 Abandoned
NCI E-181-2012-0-US-01 TumIor-Specific GM-CSF Cytokine Response as Predictor of Cancer Vaccine Effectiveness US 61/569,131 Abandoned
NCATS E-257-2010-0-BR-09 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators BR National Stage BR1120130142421 Issued